Your browser doesn't support javascript.
loading
Particle radiotherapy for breast cancer.
Ruan, Hanguang; Okamoto, Masahiko; Ohno, Tatsuya; Li, Yang; Zhou, Yuan.
Afiliação
  • Ruan H; Department of Radiation Oncology, Gunma University, Maebashi, Japan.
  • Okamoto M; Gunma University Heavy Ion Medical Center, Gunma University, Maebashi, Gunma, Japan.
  • Ohno T; Department of Radiation Oncology, Gunma University, Maebashi, Japan.
  • Li Y; Gunma University Heavy Ion Medical Center, Gunma University, Maebashi, Gunma, Japan.
  • Zhou Y; Department of Radiation Oncology, Gunma University, Maebashi, Japan.
Front Oncol ; 13: 1107703, 2023.
Article em En | MEDLINE | ID: mdl-37655110
ABSTRACT
Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy complications should not be overlooked. Common complications include dose-related coronary toxicity, radiation pneumonia, and the risk of second primary cancer of the contralateral breast. Particle radiotherapy with protons or carbon ions is widely attracting interest as a potential competitor to conventional photon radiotherapy because of its superior physical and biological characteristics. This article summarizes the results of clinical research on proton and carbon-ion radiotherapy for treating breast cancer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article